Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 21235 | Rhosin hydrochloride | 1281870-42-5 | 98% Min. |  |
| 20123102 | (R,Z)-1-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino) quinazolin-6-yl)but-2-yn-1-one O-morpholin-3-ylmethyl oxime | 1831116-75-6 | 98% Min. |  |
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot | ||||
| 20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% |  |
| Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot | ||||
| 2073103 | Remibrutinib ( LOU064 ) | 1787294-07-8 | 98% Min. |  |
| Remibrutinib ( LOU064 ) is a Potent and Highly Selective Covalent Inhibitor of Bruton | ||||
| 2071545 | Remdesivir | 1809249-37-3 | 98% Min. |  |
| Remdesivir, also known as GS-5734, is a prodrug form of the antiviral nucleoside anal | ||||
| 2071520 | RK-287107 | 2171386-10-8 | 98% Min. |  |
| RK-287107 is a potent TNKS/TNKS2 inhibitor (IC50 = 14.4 nM) with >7000-fold select | ||||
| 207101 | RBN-2397 | 2381037-82-5 | 98% Min. |  |
| 2062334 | (2R,6S)-tert-butyl 4-(4-aminobenzoyl)-2,6-dimethylpiperazine-1-carboxylate | 2161337-98-8 | 98% Min. |  |
| 202329 | (R)-methyl 2-(tert-butyldimethylsilyloxy)propanoate | 171230-81-2 | 98% Min. |  |
| 2062017 | 3-[(2RS)-tetrahydro-2H-pyran-2-yloxy]propanoic acid | 1221443-23-7 | 96% Min. | -tetrahydro-2H-pyran-2-yloxy]propanoic_acid_1221443-23-7.png) |
| 2062004 | ((1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl)methyl acetate | 1369768-29-5 | ≧95.0% | -2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl)methyl_acetate_1369768-29-5.gif) |
| 690120 | Rigosertib | 592542-59-1 | 98% Min. |  |
| Rigosertib(ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, w | ||||
| 206102 | Resatorvid | 243984-11-4 | 98% Min. |  |
| Resatorvid, also known as TAK-242, is a cell-permeable inhibitor of TLR4 signaling, b | ||||
| 204503 | RU320521 | 2262452-06-0 | 98% Min. |  |
| RU320521, also known as RU521; RU.521 is a potent and selective inhibitor of cGAS, in | ||||
| 580586 | (R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate | 2086689-88-3 | >96% |  |
| (R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate, CAS 2086689-88-3, is a v | ||||
| 193111 | Remetinostat | 946150-57-8 | >98% |  |
| Remetinostat, also known as SHP-141, is a topical formulation containing the histone | ||||
| 19355 | RG7834 | 2072057-17-9 | >98% |  |
| RG7834，also known as RO7020322, is a novel oral HBV viral gene expression inhibitor | ||||
| 19353 | RWJ-56110 | 252889-88-6 | >98% |  |
| RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks t | ||||
| 19313 | RBC8 | 361185-42-4 | >98% |  |
| RBC8 is a RalA and RalB GTPase inhibitor (EC50 ~3.5 μM). RBC8 suppresses growth of x | ||||
| 192277 | Rogaratinib | 1443530-05-9 | >98% |  |
| Rogaratinib, also known as BAY-1163877, is an aberrant fibroblast growth factor recep | ||||
| 192254 | Rebimastat | 259188-38-0 | >98% |  |
| Rebimastat, also known as BMS275291, is a sulfhydryl-based second-generation matrix m | ||||
| 192193 | Retosiban | 820957-38-8 | >98% |  |
| Retosiban, also known as GSK-221149-A; is an oral active, potent and selective, sub-n | ||||
| 19183 | RKI-1313 | 1342276-76-9 | >98% |  |
| RKI-1313 Negative control for RKI-1447 (GLXC-05200) which is a potent inhibitor of th | ||||
| 19181 | RGX-104 free form | 610318-54-2 | >98% |  |
| RGX-104, also known as SB 742881, is a liver X receptor beta agonist with potential i | ||||
| 1811151 | R547 | 741713-40-6 | >98% |  |
| R547 is orally bioavailable diaminopyrimidine cyclin-dependent kinase inhibitor (CDKI | ||||
| 1810224 | Regadenoson | 313348-27-5 | >98% |  |
| Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that | ||||
| 186251 | RMC-4550 | 2172651-73-7 | >98% |  |
| RMC-4550 is a potent and selective SHP2 inhibitor. | ||||
| 186234 | RGX-104 HCl | 610318-03-1 | >98% |  |
| RGX-104 is a liver X receptor beta agonist with potential immunomodulating and antine | ||||
| 185317 | Resminostat HCl | 1187075-34-8 | >98% |  |
| Resminostat HCl is a potent inhibitor of HDAC1/3/6. | ||||